COLL — COLLEGIUM PHARMACEUTICAL INC (Healthcare >> Drug Manufacturers - Specialty & Generic)
COLL FAQ
What is COLL's P/E ratio?
COLLEGIUM PHARMACEUTICAL INC (COLL) currently trades at a P/E ratio of 14.45.
What is COLL's ROE?
COLLEGIUM PHARMACEUTICAL INC reports a Return on Equity (ROE) of 23.99%.
What is COLL's dividend yield?
COLLEGIUM PHARMACEUTICAL INC offers a dividend yield of 0.00%.
What is COLL's Deepscope Quality Score?
Deepscope rates COLL's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy COLL?
Deepscope's AI Timing Score for COLL is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does COLL belong to?
COLLEGIUM PHARMACEUTICAL INC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NASDAQ exchange.
|
USD 33.38
Price
0.69
(2.11%)
Day Change
|
|
|---|
COLL Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 46) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROE là âm trong năm ngoái.
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Khá , ...
| Yếu tố Chất lượng |
|
48% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 89 |
| Magic Formula Rank by ROA |
1415
|
| Magic Formula Rank by ROE |
1415
|
| Magic Formula Rank by ROIC |
777
|
| Price | 33.38 |
| PBV / Sector |
3.47 / 2.76
|
| Earning Per Share | 2.31 |
| PE / Sector |
14.45 / 23.64
|
| PEG or PE/Growth / Sector |
-0.20 / 0.13
|
| Average 1M Daily Value |
13.84 M
GREAT
|
| Average 1W Daily Value |
14.79 M
GREAT
|
| Yếu tố Kỹ thuật |
|
28% |
| Sức khỏe tài chính |
|
50% |
| Khả năng kiếm lợi nhuận |
|
66% |
| Lợi tức cho nhà đầu tư |
|
4% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-06 09:09:09 |
| Symbol | COLL |
| Name | COLLEGIUM PHARMACEUTICAL INC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NASDAQ |
| Listed Shares | 32.43 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 1,082.64 / 9,835.56 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 100 Technology Center Drive, Stoughton, MA, United States, 02072
Phone: 781 713 3699
Website: https://www.collegiumpharma.com
Employees: 423
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine for severe and persistent pain that requires an extended treatment period; Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone for the management of pain severe enough to require daily; Nucynta ER and Nucynta IR, which are extended-release and immediate-release oral formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. Collegium Pharmaceutical, Inc. was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. The company was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
Google